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Summary Macrocytosis is a common finding in patients with chronic obstructive
pulmonary disease (COPD). The cause for the elevation of mean corpuscular volume
(MCV) in these patients remains elusive. In an attempt to determine the extent of
macrocytosis in COPD patients and search for possible causative factors, we
evaluated the hematologic parameters, F-cell percentage, blood gases and serum
erythropoietin (Epo) levels in 32 COPD clinically stable patients and 34 sex- and age-
matched non-smoker healthy volunteers. An increased MCV was observed in almost
half of the hypoxemic COPD cases (14/32 or 43.75%), while erythrocytosis developed
to a lesser degree (37.5%). The erythropoietic response did not correlate with the
severity of hypoxia. Moreover, no significant correlation was found between
macrocytosis and hypoxemia or erythrocytosis and red cell size. In some cases the
two phenomena occurred independently. The F-cell percentage was significantly
elevated in the COPD group (Po0:01) and was associated with MCV values (n ¼ 32;
rs ¼ 0:41; Po0:05). This finding supports the hypothesis we put forward to explain
the macrocytosis often observed in COPD, i.e., that the acute erythropoietic stress
occurring repeatedly in these patients as a result of the frequent exacerbations may
lead to waves of release of relatively immature, large red cells from the marrow,
including an increased number of F-cells, reflecting the recruitment of normally
dormant BFU-E (bursts forming units of erythrocyte precursors), which maintain the
program for g-chain synthesis. The fact that erythrocytosis and macrocytosis, both
being triggered by hypoxemia, do not occur consistently in all COPD patients
indicates that many other factors may also intervene.
& 2004 Elsevier Ltd. All rights reserved.
Introduction
Clinical experience supported by several studies
suggests that hypoxemia in chronic obstructive
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macrocytosis;1–5 this information appears also in
some textbooks of haematology.6 However, other
authors dispute this view and several reviews of
non-megaloblastic macrocytosis or relevant text-
books do not include COPD among the causes of
increased mean corpuscular volume (MCV).7–9 In
the reviewed literature, authors accepting macro-
cytosis as a possible consequence of hypoxemic
COPD either just describe the phenomenon1,3,4 or
try to interpret this by some theoretical considera-
tions;2,5 the experimental investigation of the
underlying mechanisms is still not available.
In this study, we have tried to determine the
extent of macrocytosis in COPD patients, delineate
the features of erythropoiesis and search for the
possible causative factors explaining the aberra-
tions of the erythrocytic parameters.
Materials and methods
Patients and controls
The study included 32 COPD patients (22 males and
10 females) with a median age of 60 years (range:
42–74). All cases studied were patients with
predominant bronchitis. Their arterial blood gases
were severely deranged with arterial pCO2 values
significantly increased. The patients were selected
on the basis of a well-documented diagnosis and
fulfilled the following criteria:
i. Standing hypoxemia (pO2o 65mmHg) for the
last 6 months at least. To ensure this, repeated
blood gas analyses had been made during this
period.
ii. Stable clinical condition and blood gases, i.e.,
non-aggressive disease, no change in medica-
tion, no sign of infection when blood was
collected for analysis.
iii. No evidence for renal or hepatic disease; no
congestive heart failure in advanced stage (at
least clinically); no diabetes mellitus or thyroid
dysfunction.
iv. No history of infection for at least 2 months
prior to evaluation.
v. No use of steroids, diuretics, cytotoxic drugs or
other agents that could affect blood para-
meters over the last 3 months.
Subjects who entered the study were either non-
smokers or had quitted smoking for at least 12
months prior to being evaluated. Some patients
were treated with long term oxygen. But these
patients remained hypoxemic. That’s why they
were included in the study, since arterial oxygen
saturation is considered the main stimulus leading
to increased erythropoietin production. Subjects
exhibiting laboratory findings compatible with
megaloblastic anaemia, iron-deficiency anaemia
and thalassemia trait were excluded in order to
limit the most common factors that could affect
the erythropoietic response. In addition, 34 (22
males and 12 females) sex- and age-matched non-
smoker healthy volunteers were studied as con-
trols.
After obtaining an informed consent, the follow-
ing parameters were determined: Red cell values
(RBC counts, Hct, Hb) and reticulocytes, RBC
indices (MCV, MCH, MCHC) and morphology, blood
gases, serum vitamin B12, folate, iron and ferritin
levels, serum erythropoietin (Epo) levels, and
percentage of HbF-containing cells (F-cells).
Methods
Resting arterial blood gases and pH were measured
on a 288 Blood Gas System (Ciba Corning, USA)
using a sitting sample from the radial artery.
Complete blood counts and red cell indices were
determined by a Technicon H2 analyzer (Bayer,
USA), while RBC morphology was evaluated by
optical microscopy on Giemsa stained smears. The
percentage of reticulocytes was determined vi-
sually using the standard brilliant cresyl blue stain;
from this, the absolute reticulocyte number was
calculated. Hemolysate electrophoresis was carried
out on cellulose acetate strips at alkaline pH.
Serum vitamin B12, folate, iron and ferritin levels
were estimated on an Axsym System autoanalyzer
(Abbott, USA), while serum Epo levels were
quantified with an enzyme linked immunosorbent
assay (Quantikine IVD Erythropoietin ELISA, R and D
Systems Inc. USA) on samples of blood which were
collected between 9 and 10 a.m.
The percentage of F-cells was microscopically
determined on peripheral blood smears treated
with a 0.4% formaldehyde in acetone solution to
allow both erythrocyte fixation and permeabiliza-
tion.10 HbF staining was carried out by the classical
immunocytochemical streptavidin-biotinylated al-
kaline phosphatase technique (streptABComplex/
AP, DAKOPATTS a/s Denmark) employing a mono-
clonal anti-g chain antibody (clone NaM-16-2F4
Bioatlantic, France) as the primary reagent. With
these reagents, F-cells stained red; the number and
proportion over the whole RBC population was
determined by optical microscopy under oil. Aiming
to achieve a coefficient of variation (CV) less than
10%, especially when the F-cell subset was very
low, demanded measuring a total number of red
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cells large enough to contain about 100 F-cells.
Mean F-cell proportion measured in normal indivi-
duals with the streptABComplex/AP staining pro-
cedure is in agreement with the percentages
determined by other conventional methods.11,12
Statistics
Because the values of most hematologic para-
meters were non-normally distributed, non-para-
metric tests were used for the statistical
evaluation. Differences between controls and
patients were assessed with Wilcoxon rank sum
test. The association between variables was tested
with the Spearman rank correlation test. For all
tests, significance was assumed at Po0:05:
Results
The pO2 levels of the patients ranged between 38
and 65mmHg (mean7standard deviation:
51.2711.5); values below 60mmHg were found in
24 of them (75%). Hypercapnia (pCO2445mmHg)
was observed in 20 patients (62.5%). However, in all
cases, respiratory acidosis was well compensated
and the blood pH was within normal limits
(pH47.34).
Hematologic parameters are summarized in Table
1. On the whole, the COPD patients had higher than
normal hematocrit and MCV values (Po0:001 and
Po0:001; respectively). However, the individual
values showed a large dispersion, and only 12/32
(37.5%) of the hypoxemic COPD patients had Hb
values above the upper limit taken to denote
erythrocytosis: 4meanþ 2 of the control distribu-
tion (16.12 and 14.52 g/dl for males and females,
respectively). Significant macrocytosis, defined as
an MCV495 fl, was observed in 14 patients (43.8%)
and in only 1 control (2.9%). Fig. 2 depicts the
respective distribution. The increased cell volume
was not associated with a proportional increase of
cellular hemoglobin; in fact, the MCHC values were
significantly lower than normal in the COPD group.
Reticulocytes (both as percentage and as absolute
numbers) did not differ significantly in the two
groups. On the contrary, the F-cell percentage and
the Epo levels were clearly elevated in the COPD
group. The distribution of F-cells values in the
studied populations is shown in Fig. 1.
Of the erythrocytic parameters tested, a sig-
nificant relationship was found only between
percentage of F-cells and MCV (n ¼ 32; rs ¼ 0:41;
Po0:05; Fig. 3). On the contrary, there was no
correlation between hypoxemia (pO2 values) and
total hemoglobin levels (Hb/pO2, rs ¼ 0:209;
P ¼ 0:251) and between hypoxemia and levels of
serum Epo (Epo/pO2, rs ¼ 0:256; P ¼ 0:276).
Moreover, no correlation was observed between
red cell volume and pCO2 values (MCV/pCO2, rs ¼
0:016; P ¼ 0:931).
Discussion
The erythropoietic response in hypoxemic COPD
patients remains controversial. Most authors agree
that the increase of Hct or the red cell mass often is
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Table 1 Hematologic parameters of the studied patients and controls.
Parameter Controls (n ¼ 34) COPD (n ¼ 32) Significance
Hb (g/dl) 13.870.98 15.4571.95 Po0:001
13.55 (12.5–15.8) 14.9 (12.7–21.1)
HCT (%) 41.172.90 47.976.74 Po0:001
39.8 (37.7–48) 45.6 (39.2–64)
MCV (fl) 87.5673.98 94.9975.15 Po0:001
88.2 (79.1–96.4) 94.75 (86–110)
MCHC (g/dl) 33.4870.89 32.3571.28 Po0:001
33.5 (31.4–35.6) 32.55 (29.1–34.6)
Reticulocytes (%) 1.2570.59 1.0170.58 NS
1.2 (0.3–2.6) 0.7 (0.2–3.6)
Reticulocytes 57.67729.04 54.5742.48 NS
(absolute number,  103/ml) 50.2 (13.2–121.6) 36 (9.7–200.7)
F cells (%) 2.8271.99 4.8172.86 Po0:01
2.45 (0.1–8.3) 4.15 (0.5–12.7)
Epo(mU/ml) 5.474.76 9.5975.95 Po0:05
5.4 (1–14.9) 8.4 (2.5–27.7)
Values are expressed as mean7standard deviation, while numbers in italics denote median values and range limits.
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Figure 1 Distribution of F-cell percentages in normal subjects (NORMAL) and patients with chronic pulmonary disease
(COPD).
Figure 2 MCV values of patients and controls. The dotted line represents the upper limit of normal (95 fl).
Figure 3 Statistically significant relationship between red cell size (MCV) and F-cell percentages (n ¼ 32; rs ¼ 0:41;
Po0:05) in COPD patients. The ideal line is shown for comparison.
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not as high as that observed in normal subjects
living at high altitudes, while in certain patients is
totally absent.4,5,13,14 Up to now, although several
factors have been proposed to explain the varying
erythropoietic response among COPD patients with
the same degree of hypoxemia, the complete
picture of the pathophysiology of the whole
phenomenon is not available. In this study only 12
out of 32 (37.5%) hypoxemic COPD patients devel-
oped erythrocytosis, the magnitude of which did
not correlate neither with the severity of hypox-
emia nor with the serum Epo levels observed in
each patient, although, the latter were signifi-
cantly higher in the group of patients with COPD. To
be added, that most of the factors that have been
incriminated for the varying erythropoietic re-
sponse in earlier similar surveys (serum iron,
vitamin B12 or folate deficiency, hypercapnia and
infection) do not seem to play a significant role in
this study since the above parameters were
thoroughly checked.
A notable finding of this study is the presence of
mild macrocytosis (95–110 fl) in almost half of our
hypoxemic COPD cases (14/32 or 43.75%). These
results are broadly in accordance with those of
O’Neil et al.1 and Cook.2 The stable condition of
our patients, the complete metabolic compensa-
tion in those who had high CO2 levels and the lack
of correlation between these and the respective
MCV values are not consistent with the older view
that acidosis or CO2 retention may account for the
macrocytosis observed in patients with COPD.5
Another interesting finding of the study is the
increase of F-cell percentage in patients and its
significant correlation with MCV values. It is known
that in erythropoietic stress, the sharp increase in
Epo levels initially mobilizes the relatively differ-
entiated erythroid precursors, namely colony form-
ing units (CFUe’s) and erythroblasts. If the strong
stimulus is sustained or repeated, it may result in
the depletion of these cellular compartments in the
marrow. Further demand for erythrocytes is met by
direct recruitment of progenitors from the more
primitive burst forming unit (BFUe) pool. The
prematurely maturing BFUe’s retain their potential
for haemoglobin g-chain synthesis, unlike BFUe’s
differentiated under normal conditions.15–19 This
association, i.e., acute erythropoiesis, significant
macrocytosis and increased presence of F-cells in
the blood has been repeatedly reported in the
literature.15,20,21 Thus, our observations in COPD
suggest the development of a similar mechanism in
these patients.
It could be argued that an elevation in MCV value
may be the result of reticulocytosis. However, none
of our patients presented with significantly in-
creased reticulocytes and we have not found any
correlation between MCV and relative or absolute
reticulocyte count. Reticulocytosis is rather un-
common in COPD. The production of reticulocytes
depends on an adequate CFUe compartment,17 and
besides, these immature red cells are short-lived. It
is therefore unlikely that reticulocytosis may
increase MCV, except for the first few days after
an acute hypoxic episode.
To our knowledge, erythrocytosis in high altitude
dwellers is not associated with macrocytosis.22
However, this finding concerns normal subjects,
whose hypoxemia is permanent and stable, thus
allowing a complete adaptation of erythropoiesis to
a higher than normal red cell production without
the need for direct recruitment of primitive
erythroid progenitors. On the contrary, COPD
patients have episodes of hypoxemia whose fre-
quency, severity and duration show a large varia-
tion: moreover, nocturnal apnea severely
aggravating oxygen desaturation is well recognized
in some COPD cases.23 Consequently, COPD patients
have every reason to develop frequent episodes of
acute erythropoietic stress and these may lead to
conditions where red cell production is acute and
premature, hence macrocytic.
However, the red cell size did not show any
significant correlation with the severity of hypox-
emia or the total Hct increase. In fact, in some
cases, the two phenomena (erythrocytosis and
macrocytosis) developed independently. This ob-
servation implies that, although the two phenom-
ena may have a common cause (tissue hypoxiaF
increased production and secretion of Epo), many
other factors intervene and affect each of them in
a different way. For instance, the systemic effects
of the chronic inflammation characterizing COPD24
and some of the drugs prescribed for these patients
may also influence erythropoiesis.25 Moreover,
interference of additional factors between hypox-
emia and the final erythropoietic response (ery-
throcytosis and/or macrocytosis) may also be
proposed to explain the unexpected absence of
statistically significant correlation between the
levels of serum Epo and the percentages of F-cell,
or the levels of Epo and the values of MCV. Within
this context, it must be noted that:
(a) Epo production and release due to hypoxia is a
fast responding mechanism. Consequently, in-
stant Epo values do not accurately reflect the
dynamics of Epo production and release.26,27
(b) The extent of recruitment from BFUe’s is not
determined solely by the degree of Epo
stimulation, since it may also depend on the
size of the compartments of CFU-E’s and
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erythroblasts at the time of exposure to the
acute hypoxemic and hence, acute erythro-
poietic stress.16,17
(c) The rate of F-cell production is influenced also
by other factors, including sex,28 age29 and
genetic features.30,31
In conclusion, our data show that half of
hypoxemic COPD patients present macrocytosis
which is associated, at least to some degree, with
an increased F-cell production. We postulate that
the common factor of these changes is enhanced
release of premature red cells from the bone
marrow resulting from acute hypoxemic episodes
which lead to phases of acute erythropoietic stress.
However, the fact that several other expected
correlations were not proven, implies that the
erythropoietic response in respiratory failure is
affected by many factors, other than the degree of
hypoxemia. Accordingly, further studies are still
needed in order to fully explore the complex
aspects of this multifactorial process.
Acknowledgements
We thank the Greek State Scholarships Foundation
for supporting this work.
References
1. O’ Neil BJ, Marlin GE, Streeter AM. Red cell macrocytosis
in chronic obstructive airway disease. Med J Austr
1972;i:283.
2. Cook MK. Red cell macrocytosis and COPD. Br J Haematol
1993;83:174–6.
3. Thong KL, Hanley SA, McBride JA. Clinical significance of a
high mean corpuscular volume in non-anemic patients. Can
Med Ass J 1977;117:908–10.
4. Gallo RC, Fraimow W, Cathcart RT, Erslev AJ. Erythropoietic
response in chronic pulmonary disease. Arch Intern Med
1964;113:559–68.
5. Freedman BJ, Penington DG. Erythrocytosis in emphysema.
Br J Haematol 1963;9:425–30.
6. Lee GR. Megaloblastic and nonmegaloblastic macrocytic
anemias. In: Lee GR, Bithell TC, Foerster J, Athens JW,
Lukens JN, editors. Wintrobe’s Clinical Hematology. Phila-
delphia: Lea and Febiger; 1993. p. 745–90.
7. Breedveld FC, Bierger R, Van Wermeskerken R. The clinical
significance of macrocytosis. Acta Med Scand 1981;209:
319–22.
8. Boothroyd CM, Stainsby D, Simpson FG. Red cell macro-
cytosis and chronic obstructive airways disease. Br
J Haematol 1992;81:453–4.
9. Berliner N, Duffy TP. Approach to the patient with anemia.
In: Hoffman R, Benz Jr. EJ, Shattil SJ, Furie B, Cohen HJ,
editors. Hematology: basic principles and practice. New
York: Churchill-Livingstone; 1991. p. 302–11.
10. Tsantes A, Androutsos G, Bonovas S, et al. Assessment of a
new immunocytochemical technique in HbF-cell counting by
a novel objective evaluation method. Br J Haematol
2003;123:948–51.
11. Wood WG, Stamatoyannopoylos G, Lim G, Nute PE. F-Cells in
the adult: normal values and levels in individuals with
hereditary and acquired elevations of HbF. Blood
1975;46:671–82.
12. Thein SL, Craig JE. Genetics of HbF/F cells variance in adults
and heterocellular hereditary persistence of fetal hemoglo-
bin. Hemoglobin 1998;22:401–14.
13. Guidet B, Offestadt G, Boffa G, et al. , Polycythemia in
COPD. A study of serum and urine erythropoietin
and medullary erythroid progenitors. Chest 1987;92:
867–70.
14. Murray JF. Classification of polycythemic disorders with
comments on the diagnostic value of arterial oxygen
analysis. Ann Int Med 1966;64:892–903.
15. Papayannopoulou T, Abkowitz J, D’Andrea A. Biology of
erythropoiesis, erythroid differentiation and maturation. In:
Hoffman R, Benz Jr. EJ, Shattil SJ, Furie B, Cohen HJ,
Silberstein LE, McGlave P, editors. Hematology: basic
principles and practice. New York: Churchill-Livingstone;
2000. p. 202–19.
16. Papayanopoulou T, Vichinsky E, Stamatoyannopoulos G.
Fetal hemoglobin production during acute erythroid expan-
sion. Observations in patients with transient erythroblasto-
penia and post-phlebotomy. Br J Haematol 1980;44:
535–46.
17. Nute PE, Papayanopoulou T, Chen P, Stamatoyannopoulos G.
Acceleration of F-cell production in response to experimen-
tally induced anemia in adult baboons (Papio cynocephalus).
Am J Hematol 1980;8:157–68.
18. Dover JG, Boyer HS, Zinkham HW. Production of erythro-
cytes that contain fetal hemoglobin in anemia. J Clin Invest
1979;63:173–6.
19. De Simone J, Biel M, Heller P. Maintenance of HbF elevations
in the baboon by prolonged erythropoietic stress. Blood
1982;60:519–23.
20. Alter BP, Rappeport JM, Huisman TH, Schroeder WA, Nathan
DG. Fetal erythropoiesis following bone marrow transplan-
tation. Blood 1976;48:843–53.
21. Sieff CA, Nathan DG. The anatomy and physiology of
hematopoiesis. In: Nathan DG, Oski FA, editors. Hematology
of infancy and childhood. Philadelphia: WB Saunders Co;
1993. p. 156–215.
22. Vanier T, Dulfano M, Wu C, Desforges J. Emphysema, hypoxia
and polycythemic response. New Eng J Med 1963;269:
169–78.
23. Douglas NJ, Calverley PM, Leggett RJ, Brash HM, Flenley DC,
Brezinova V. Transient hypoxemia during sleep in chronic
bronchitis and emphysema. Lancet 1979;1:1–4.
24. Faquin WC, Schneider TJ, Goldberg MA. Effect of inflamma-
tory cytikines on hypoxia-induced erythropoietin produc-
tion. Blood 1992;79:1987–94.
25. Oren R, Beeri M, Hubert A, et al. , Effect of theophylline on
erythrocytosis in chronic obstructive pulmonary disease.
Arch Int Med 1997;157:1474–8.
26. Mancini MM, Birbault P, Hannhort B, et al. , Evaluation
of serum erythropoietin after provoked hypoxaemia in
patients with chronic respiratory failure. Eur Resp
J 1992;5(suppl 15):49.
27. Eckardt KU, Boutellier U, Kurtz A, Schopen M, Koller EA,
Bauer C. Rate of erythropoietin formation in humans in
response to acute hypobaric hypoxia. J Appl Physiol
1989;66:1785–8.
ARTICLE IN PRESS
1122 A.E. Tsantes et al.
28. Rutland PC, Pembrey ME, Davies T. The estimation of fetal
hemoglobin in healthy adults by radioimmunoassay. Br
J Haematol 1983;3:673–82.
29. De Simone J, Heller P, Biel M, Zwiers D. Genetic relationship
between fetal Hb levels in normal and erythropoietically
stressed baboons. Br J Haematol 1981;49:175–83.
30. Zago MA, Wood WG, Clegg JB, Weatherall DJ, O’ Sullivan M,
Gunson H. Genetic control of F cells in human adults. Blood
1979;53:977–86.
31. Sampietro M, Thein SL, Contreras M, Pazmany L. Variation of
HbF and F-cell number with the G-g Xmn I (C-T) polymorph-
ism in normal individuals. Blood 1992;79:832–9.
ARTICLE IN PRESS
Red cell macrocytosis in hypoxemic patients with chronic obstructive pulmonary disease 1123
